The Oncology Institute Reports Fourth Quarter and Full Year 2025 Financial Results and Guidance for 2026
The Oncology Institute, Inc. (TOI)
Company Research
Source: GlobeNewswire
CERRITOS, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its fourth quarter and year ended December 31, 2025. Recent Operational Highlights Cash flow from operations in Q4 2025 was approximately $3.2 million, due to disciplined working capital management and overall increase in gross profit marginContinued expansion of our capitated footprint, initiating 9 new capitated contracts during 2025 in CA, FL, and NV, representing approximately 260,000 additional lives under managementFurther ramped our capitation partnership with Elevance in Florida during the fourth quarter and remains on track to continue expansion across the state in 2026 which would more than double the current partnershipInitiated capitation agreements with Humana and CarePlus in Florida during the fourth quarter, further expanding pa
Show less
Read more
Impact Snapshot
Event Time:
TOI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TOI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TOI alerts
High impacting The Oncology Institute, Inc. news events
Weekly update
A roundup of the hottest topics
TOI
News
- Oncology Institute (TOI) had its price target raised by B. Riley Financial, Inc. from $6.00 to $8.00. They now have a "buy" rating on the stock.MarketBeat
- The Oncology Institute Inc (TOI) Q4 2025 Earnings Call Highlights: Record Revenue and First ... [Yahoo! Finance]Yahoo! Finance
- Oncology Institute Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- Oncology Institute (TOI) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $5.00 price target on the stock.MarketBeat
- Oncology Institute (TOI) had its "buy" rating reaffirmed by BTIG Research. They now have a $7.00 price target on the stock.MarketBeat
TOI
Earnings
- 3/12/26 - Beat
TOI
Sec Filings
- 3/20/26 - Form 3
- 3/18/26 - Form 4
- 3/18/26 - Form 4
- TOI's page on the SEC website